Production of Specialities and Innovative Dosage Forms

Glatt engineering services to manufacture special pharmaceuticals, new delivery forms and medical devices

Specific processes tailored to the complexities of manufacturing advanced formulations

Are you looking for a project partner for the planning and realization of your medical device manufacturing project? You have found it.

In the ever-evolving pharmaceutical landscape, the development of specialty and innovative dosage forms represents the cutting edge of drug delivery technology. These novel formulations, ranging from controlled-release systems to nanoencapsulated drugs, offer unprecedented opportunities to enhance therapeutic efficacy, patient compliance, and treatment outcomes. Glatt Process & Plant Engineering is at the forefront of this innovation wave, delivering comprehensive engineering solutions that bring these advanced products from concept to reality.

The creation of specialty and innovative dosage forms demands a blend of creativity, scientific rigor, and technical expertise. Our multidisciplinary team thrives in this environment, bringing together experts in pharmacology, material science, and engineering not only from Glatt to tackle the unique challenges presented by each new project.

Leveraging single-use systems in OSD and biopharmaceutical and sterile pharmaceutical productions

In the ever-evolving pharmaceutical manufacturing landscape, the adoption of single-use systems in the production of oral solid dosage (OSD) and biopharmaceutical and sterile pharmaceutical forms represents a promising shift towards enhanced efficiency, flexibility, and safety. Glatt, as a pioneer in process technology, is at the forefront of integrating single-use systems into OSD and biopharmaceutical and sterile pharmaceutical production, helping manufacturers overcome traditional challenges and embrace the future of pharmaceutical manufacturing.

Single-use systems are particularly beneficial in the production of OSD, biologics and sterile pharmaceuticals where contamination control and operational efficiency are paramount. These systems eliminate the need for extensive cleaning and sterilization required by traditional stainless steel equipment, significantly reducing the risk of cross-contamination and enabling faster product changeovers.

With single-use systems, pharmaceutical manufacturers can achieve greater flexibility, enhance safety, and accelerate time to market for their products. Glatt is committed to guiding companies through the complexities of adopting these technologies and providing the expertise needed to optimize production processes.